Thomas B. King

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Bothell, WA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Sandra Thomson as attorney-in-fact for Thomas B. King
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Thomas B. King

Form 4 holding Director

ACHIEVE LIFE SCIENCES, INC.

Security class
Performance Restricted Stock Unit (PRSU)
Shares / value
0
Estimated value
$1,669,850
Report date
04 Sep 2025
Price
$3.67
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

TFF Pharmaceuticals, Inc.

Security class
Restricted stock units
Shares / value
3,110
Estimated value
$1,218
Report date
18 Apr 2024
Price
$0.3916
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding Director

TFF Pharmaceuticals, Inc.

Security class
Stock Options (Right to Buy)
Shares / value
1,583
Estimated value
Report date
03 Jul 2024
Price
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding Director

Satsuma Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
08 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Thomas B. King

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .